PHASE-I AND PHARMACOKINETIC STUDY OF 5-AZA-2'-DEOXYCYTIDINE (NSC 127716) IN CANCER-PATIENTS

被引：1
|
作者：
VANGROENINGEN, CJ
LEYVA, A
OBRIEN, AMP
GALL, HE
PINEDO, HM
机构：
来源：
CANCER RESEARCH | 1986年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4831 / 4836
页数：6
相关论文
共 50 条
  • [21] Proteomic Analysis of Liver Cancer Cells Treated With 5-Aza-2′-Deoxycytidine (AZA)
    Bai, Shujun
    Tong, Aiping
    Lau, Quek Choon
    Liu, Rui
    Tang, Minghai
    Chen, Lijuan
    Huang, Canhua
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (01) : 22 - 34
  • [22] PHARMACOKINETICS OF 2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE (NSC-264137) IN CANCER-PATIENTS - PHASE-I STUDY
    GOUYETTE, A
    HUERTAS, D
    DROZ, JP
    ROUESSE, J
    AMIEL, JL
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12): : 1285 - 1292
  • [23] PHASE-I AND PHARMACOKINETIC STUDY OF TIAZOFURIN (NSC-286193)
    RAGHAVAN, D
    BISHOP, J
    LEVI, J
    FOX, R
    HEDLEY, D
    WOODS, R
    COX, K
    COATES, A
    TATTERSALL, M
    HILLCOAT, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 167 - 167
  • [24] 5-aza-2′-Deoxycytidine Enhances the Radiosensitivity of Breast Cancer Cells
    Wang, Li
    Zhang, Yong
    Li, RongQing
    Chen, Yue
    Pan, XinYan
    Li, GuiYun
    Dai, Fang
    Yang, JuLun
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (01) : 34 - 44
  • [25] 5-AZA-2′-deoxycytidine in cancer immunotherapy:: A mouse to man story
    Coral, Sandra
    Sigalotti, Luca
    Covre, Alessia
    Nicolay, Hugues J. M.
    Natali, Pier Giorgio
    Maio, Michele
    CANCER RESEARCH, 2007, 67 (06) : 2900 - 2901
  • [26] 5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer
    Aditi Patra
    Moonmoon Deb
    Rajvir Dahiya
    Samir Kumar Patra
    Clinical Epigenetics, 2011, 2 : 339 - 348
  • [27] 5-Aza-2'-deoxycytidine stress response and apoptosis in prostate cancer
    Patra, Aditi
    Deb, Moonmoon
    Dahiya, Rajvir
    Patra, Samir Kumar
    CLINICAL EPIGENETICS, 2011, 2 : 339 - 348
  • [28] Results of a phase I/II study of the combination of 5-aza-2′deoxycytidine (DAC) and valproic acid (VPA) in patients (pts) with leukemia
    Garcia-Manero, G
    Kantarjian, H
    Sanchez-Gonzalez, B
    Faderl, S
    Verstovsek, S
    Ravandi, F
    Ryttling, M
    Cortes, J
    Wierda, W
    Hoshino, K
    Yang, H
    Santos-Malave, C
    Fiorentino, J
    Jabbour, E
    Rosner, G
    Issa, JP
    BLOOD, 2004, 104 (11) : 78A - 79A
  • [29] PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS
    DEFORNI, M
    BUGAT, R
    CHABOT, GG
    CULINE, S
    EXTRA, JM
    GOUYETTE, A
    MADELAINE, I
    MARTY, ME
    MATHIEUBOUE, A
    CANCER RESEARCH, 1994, 54 (16) : 4347 - 4354
  • [30] Inhibition of DNA methylation by continuous infusion of 5-Aza-2′-Deoxycytidine (Decitabine):: A phase I study with molecular goals
    Leachman, S
    Jones, D
    Karpf, A
    Florell, S
    Porter-Gill, P
    Wheeler, R
    Samlowsk, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 538 - 538
12345